» Articles » PMID: 32419552

Atrioventricular Valve Regurgitation in Single Ventricle Heart Disease: A Common Problem Associated With Progressive Deterioration and Mortality

Abstract

The Fontan procedure has provided patients with single ventricle physiology extended survival into adulthood and in many cases has improved their quality of life. Atrioventricular valve regurgitation (AVVR) is common in single ventricle patients and is associated with increased risk of mortality. AVVR is more common in patients with a systemic tricuspid or common atrioventricular valve but is generally progressive irrespective of underlying valve morphology. AVVR can be attributable to diverse structural and functional abnormalities at multiple levels of the valvar apparatus, as well as ventricular dysfunction and dilation. Multiple imaging modalities including recent advances in 3-dimensional echocardiography and cross-sectional imaging have been used to further understand AVVR. Surgery to address AVVR must be tailored to the underlying mechanism and the timing of surgical repair should be chosen carefully. In this review, we discuss the etiologies, treatment options, surgical timing, and outcomes of valve repair or replacement for AVVR in patients with single ventricle congenital heart disease, with a focus on those with a Fontan circulation as AVVR is associated with increased risk for Fontan failure and mortality. In-depth understanding of the current literature will help guide clinicians in their approach and management of AVVR in this population.

Citing Articles

ADEPT: A Noninvasive Method for Determining Elastic Parameters of Valve Tissue.

Wu W, Daneker M, Herz C, Dewey H, Weiss J, Pouch A ArXiv. 2025; .

PMID: 39990796 PMC: 11844617.


Assessment of hemodynamic disturbances and impaired ventricular filling in asymptomatic fontan patients: A 4D flow CMR study.

Hu L, Zhao X, Leng S, Ouyang R, Wang Q, Sun A Eur J Radiol Open. 2025; 14:100631.

PMID: 39868414 PMC: 11762912. DOI: 10.1016/j.ejro.2024.100631.


Mid-term outcomes of atrioventricular valve repair in functional single ventricle patients.

Jin Y, Wu Q, Zhang X, Fan L, Zhang E, Xue H Front Cardiovasc Med. 2025; 11:1510143.

PMID: 39744207 PMC: 11688645. DOI: 10.3389/fcvm.2024.1510143.


Thyroid dysfunction in pediatric Fontan patients is associated with unfavorable hemodynamic status and severity of protein-losing enteropathy: A report from the Fontan care network.

Sweer J, Germund I, Khalil M, Apitz C, Ten Dam K, Wendt S Int J Cardiol Congenit Heart Dis. 2024; 13:100475.

PMID: 39712226 PMC: 11657406. DOI: 10.1016/j.ijcchd.2023.100475.


High-Performing Fontan Patients: A Fontan Outcome Registry by Cardiac Magnetic Resonance Imaging Study.

Alsaied T, Li R, Christopher A, Fogel M, Slesnick T, Krishnamurthy R JACC Adv. 2024; 3(10):101254.

PMID: 39309667 PMC: 11414658. DOI: 10.1016/j.jacadv.2024.101254.


References
1.
Diller G, Kempny A, Alonso-Gonzalez R, Swan L, Uebing A, Li W . Survival Prospects and Circumstances of Death in Contemporary Adult Congenital Heart Disease Patients Under Follow-Up at a Large Tertiary Centre. Circulation. 2015; 132(22):2118-25. DOI: 10.1161/CIRCULATIONAHA.115.017202. View

2.
Pundi K, Johnson J, Dearani J, Pundi K, Li Z, Hinck C . 40-Year Follow-Up After the Fontan Operation: Long-Term Outcomes of 1,052 Patients. J Am Coll Cardiol. 2015; 66(15):1700-10. DOI: 10.1016/j.jacc.2015.07.065. View

3.
Laux D, Vergnat M, Lambert V, Gouton M, Ly M, Peyre M . Atrio-ventricular valve regurgitation in univentricular hearts: outcomes after repair†. Interact Cardiovasc Thorac Surg. 2015; 20(5):622-9. DOI: 10.1093/icvts/ivv011. View

4.
Rychik J . The Relentless Effects of the Fontan Paradox. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2016; 19(1):37-43. DOI: 10.1053/j.pcsu.2015.11.006. View

5.
Acharya G, Wilsgaard T, Berntsen G, Maltau J, Kiserud T . Reference ranges for serial measurements of umbilical artery Doppler indices in the second half of pregnancy. Am J Obstet Gynecol. 2005; 192(3):937-44. DOI: 10.1016/j.ajog.2004.09.019. View